Time to deterioration of patient-reported outcomes in non-small cell lung cancer: exploring different definitions.
| Publicado en: | Quality of Life Research Vol. 31; no. 8; pp. 2535 - 2544 |
|---|---|
| Autores principales: | , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Aug2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=157776265&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 157776265 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 09629343 GPQ jtl: Quality of Life Research issn: 09629343 maglogo: N pubinfo: dt: Aug2022 vid: 31 iid: 8 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 157776265 154977711 155925223 10.1007/s11136-022-03088-0 157776265 ppf: 2535 ppct: 9 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Time to deterioration of patient-reported outcomes in non-small cell lung cancer: exploring different definitions. aug: au: Walding, Andrew Skaltsa, Konstantina Casamayor, Montserrat Rydén, Anna affil: AstraZeneca R&D, 132 Hills Road, CB2 1PG, Cambridge, UK sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|